Desoxycorticosterone acetate
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Percorten Acetate, Decosterone, others |
| Other names | DOCA; 11-Deoxycorticosterone 21-acetate; 21-Acetoxypregn-4-ene-3,20-dione |
| Routes of administration |
Intramuscular injection |
| Drug class | Corticosteroid; Mineralocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.251 |
| Chemical and physical data | |
| Formula | C23H32O4 |
| Molar mass | 372.505 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Desoxycorticosterone acetate (also known as DOCA and 11-deoxycorticosterone 21-acetate and sold under the brand names Percorten Acetate and Decosterone, among others) is a mineralocorticoid medication and a mineralocorticoid ester. It is formulated as an oil solution and is administered once daily by intramuscular injection. The medication is the C21 acetate ester of 11-deoxycorticosterone.
| Mineralocorticoids | |
|---|---|
| Antimineralocorticoids | |
| Synthesis modifiers | |
| |
| PR |
|
||||||
|---|---|---|---|---|---|---|---|
|
mPR (PAQR) |
|
||||||